{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:05:41Z","timestamp":1788455141793,"version":"build-2803163510"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.01002","type":"journal-article","created":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T06:23:29Z","timestamp":1594189409000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["O-1602, an Agonist of Atypical Cannabinoid Receptors GPR55, Reverses the Symptoms of Depression and Detrusor Overactivity in Rats Subjected to Corticosterone Treatment"],"prefix":"10.3389","volume":"11","author":[{"given":"Andrzej","family":"Wr\u00f3bel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Serefko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Szopa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ulrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Poleszak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Rechberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1464-410X.2007.07205.x","article-title":"Muscarinic receptor antagonists for overactive bladder","volume":"100","author":"Abrams","year":"2007","journal-title":"BJU Int."},{"key":"B2","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.pharep.2015.12.009","article-title":"The effect of O-1602, an atypical cannabinoid, on morphine-induced conditioned place preference and physical dependence","volume":"68","author":"Alavi","year":"2016","journal-title":"Pharmacol. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.biopha.2017.12.056","article-title":"Orphan G protein-coupled receptors: The role in CNS disorders","volume":"98","author":"Alavi","year":"2018","journal-title":"BioMed. Pharmacother."},{"key":"B4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00192-015-2802-x","article-title":"Cannabinoid receptor expression in the bladder is altered in detrusor overactivity","volume":"27","author":"Bakali","year":"2016","journal-title":"Int. Urogynecol. J."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tips.2005.11.003","article-title":"In silico patent searching reveals a new cannabinoid receptor","volume":"27","author":"Baker","year":"2006","journal-title":"Trends Pharmacol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11255-019-02128-y","article-title":"Uroprotective effect of ambroxol in cyclophosphamide-induced cystitis in mice","volume":"51","author":"Barut","year":"2019","journal-title":"Int. Urol. Nephrol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.neulet.2011.12.039","article-title":"The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain","volume":"508","author":"Breen","year":"2012","journal-title":"Neurosci. Lett."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/s0024-3205(01)01182-1","article-title":"Effects of anesthesia on cystometry and leak point pressure of the female rat","volume":"69","author":"Cannon","year":"2001","journal-title":"Life Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/intimm\/dxu097","article-title":"The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells","volume":"27","author":"Chiurchiu","year":"2015","journal-title":"Int. Immunol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"B11","doi-asserted-by":"publisher","first-page":"3908","DOI":"10.1111\/bph.12746","article-title":"Activation of GPR18 by cannabinoid compounds: a tale of biased agonism","volume":"171","author":"Console-Bram","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1124\/mol.115.099333","article-title":"The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray","volume":"88","author":"Deliu","year":"2015","journal-title":"Mol. Pharmacol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1463-1326.2011.01515.x","article-title":"The atypical cannabinoid O-1602 stimulates food intake and adiposity in rats","volume":"14","author":"Diaz-Arteaga","year":"2012","journal-title":"Diabetes Obes. Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1016\/j.neuroscience.2006.06.007","article-title":"Peptidergic sensory and parasympathetic fiber sprouting in the mucosa of the rat urinary bladder in a chronic model of cyclophosphamide-induced cystitis","volume":"141","author":"Dickson","year":"2006","journal-title":"Neuroscience"},{"key":"B15","article-title":"Directive 2010\/63\/EU of the European Parliament and of the Council of 22\u00a0September 2010 on the protection of animals used for scientific purposes","year":""},{"key":"B16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neuroscience.2013.04.060","article-title":"Inflammatory cytokines in depression: neurobiological mechanisms and therapeutic implications","volume":"246","author":"Felger","year":"2013","journal-title":"Neuroscience"},{"key":"B17","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2174\/157015911798376253","article-title":"Neurotrophins in the lower urinary tract: becoming of age","volume":"9","author":"Frias","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1007\/s13311-018-0610-y","article-title":"Alterations in Gene and Protein Expression of Cannabinoid CB2 and GPR55 Receptors in the Dorsolateral Prefrontal Cortex of Suicide Victims","volume":"15","author":"Garcia-Gutierrez","year":"2018","journal-title":"Neurotherapeutics"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/545048","article-title":"The effects of tempol on cyclophosphamide-induced oxidative stress in rat micturition reflexes","volume":"2015","author":"Gonzalez","year":"2015","journal-title":"ScientificWorldJournal"},{"key":"B20","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1569-9056(09)60596-0","article-title":"Distribution of the G-protein-coupled receptor 55 (GPR55) in the rat bladder and urodynamic effects of a selective GPR55-agonist in conscious rats","author":"Gratzke","year":"2009","journal-title":"Eur. Urol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.urology.2008.03.044","article-title":"Functional and immunohistochemical characterization of CB1 and CB2 receptors in rat bladder","volume":"72","author":"Hayn","year":"2008","journal-title":"Urology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bbi.2018.11.017","article-title":"Activation of GPR55 induces neuroprotection of hippocampal neurogenesis and immune responses of neural stem cells following chronic, systemic inflammation","volume":"76","author":"Hill","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"B23","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.urology.2007.02.069","article-title":"Effects of IP-751, ajulemic acid, on bladder overactivity induced by bladder irritation in rats","volume":"70","author":"Hiragata","year":"2007","journal-title":"Urology"},{"key":"B24","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.urology.2012.04.019","article-title":"Risk factors for new-onset overactive bladder in older subjects: results of the Fujiwara-kyo study","volume":"80","author":"Hirayama","year":"2012","journal-title":"Urology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1002\/hipo.22747","article-title":"A putative lysophosphatidylinositol receptor GPR55 modulates hippocampal synaptic plasticity","volume":"27","author":"Hurst","year":"2017","journal-title":"Hippocampus"},{"key":"B26","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.brainres.2010.08.078","article-title":"Pharmacological characterization of repeated corticosterone injection-induced depression model in rats","volume":"1359","author":"Iijima","year":"2010","journal-title":"Brain Res."},{"key":"B27","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1038\/sj.bjp.0707419","article-title":"The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects","volume":"152","author":"Johns","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00109-012-0957-1","article-title":"O-1602, an atypical cannabinoid, inhibits tumor growth in colitis-associated colon cancer through multiple mechanisms","volume":"91","author":"Kargl","year":"2013","journal-title":"J. Mol. Med. (Berl.)"},{"key":"B29","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1159\/000447205","article-title":"Overactive bladder syndrome: evaluation and management","volume":"11","author":"Leron","year":"2018","journal-title":"Curr. Urol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/MPA.0b013e318259f6f0","article-title":"Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice","volume":"42","author":"Li","year":"2013","journal-title":"Pancreas"},{"key":"B31","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1111\/j.1365-2982.2011.01742.x","article-title":"A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents","volume":"23","author":"Lin","year":"2011","journal-title":"Neurogastroenterol. Motil."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1016\/j.eururo.2006.10.028","article-title":"Acetylcholine and molecular components of its synthesis and release machinery in the urothelium","volume":"51","author":"Lips","year":"2007","journal-title":"Eur. Urol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1111\/dom.12780","article-title":"GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans","volume":"18","author":"Liu","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1007\/s00192-018-3817-x","article-title":"Analysis of key genes and micro-RNA-mRNA regulatory networks in women with ulcerative interstitial cystitis\/pain bladder syndrome","volume":"30","author":"Liu","year":"2019","journal-title":"Int. Urogynecol. J."},{"key":"B35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1097\/FBP.0000000000000068","article-title":"Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain","volume":"25","author":"Marco","year":"2014","journal-title":"Behav. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1471-2202-11-44","article-title":"N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor","volume":"11","author":"McHugh","year":"2010","journal-title":"BMC Neurosci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1038\/sj.bjp.0707464","article-title":"GPR55: a new member of the cannabinoid receptor clan","volume":"152","author":"Pertwee","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-319-20825-1_1","article-title":"Endocannabinoids and Their Pharmacological Actions","volume":"231","author":"Pertwee","year":"2015","journal-title":"Handb. Exp. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.lfs.2018.09.058","article-title":"Cannabinoids in depressive disorders","volume":"213","author":"Poleszak","year":"2018","journal-title":"Life Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.brainresbull.2019.05.021","article-title":"Influence of the CB1 cannabinoid receptors on the activity of the monoaminergic system in the behavioural tests in mice","volume":"150","author":"Poleszak","year":"2019","journal-title":"Brain Res. Bull."},{"key":"B41","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/fcp.12099","article-title":"Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats","volume":"29","author":"Rahimi","year":"2015","journal-title":"Fundam. Clin. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1016\/S0022-5347(05)00322-8","article-title":"Botulinum toxin type a inhibits calcitonin gene-related peptide release from isolated rat bladder","volume":"175","author":"Rapp","year":"2006","journal-title":"J. Urol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bcp.2018.06.001","article-title":"Molecular and functional interaction between GPR18 and cannabinoid CB2 G-protein-coupled receptors. Relevance in neurodegenerative diseases","volume":"157","author":"Reyes-Resina","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/nau.23277","article-title":"Severe depression and anxiety in women with overactive bladder","volume":"37","author":"Ribeiro Melotti","year":"2018","journal-title":"Neurourol. Urodyn."},{"key":"B45","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1002\/ibd.21538","article-title":"The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment","volume":"17","author":"Schicho","year":"2011","journal-title":"Inflammation Bowel Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.neulet.2011.06.004","article-title":"The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55","volume":"500","author":"Schuelert","year":"2011","journal-title":"Neurosci. Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13041-017-0318-7","article-title":"The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress","volume":"10","author":"Shi","year":"2017","journal-title":"Mol. Brain"},{"key":"B48","first-page":"37","article-title":"Distribution and colocalization of calcitonin gene-related peptide, tachykinins, and vasoactive intestinal peptide in normal and idiopathic unstable human urinary bladder","volume":"77","author":"Smet","year":"1997","journal-title":"Lab. Invest."},{"key":"B49","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.pain.2008.04.006","article-title":"The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain","volume":"139","author":"Staton","year":"2008","journal-title":"Pain"},{"key":"B50","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s00345-002-0301-4","article-title":"Prevalence and burden of overactive bladder in the United States","volume":"20","author":"Stewart","year":"2003","journal-title":"World J. Urol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1002\/nau.22978","article-title":"The effect of combined treatment with a beta3 AR agonist and a ROCK inhibitor on detrusor overactivity","volume":"36","author":"Wrobel","year":"2017","journal-title":"Neurourol. Urodyn."},{"key":"B52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.vascn.2015.04.006","article-title":"A new model of detrusor overactivity in conscious rats induced by retinyl acetate instillation","volume":"74","author":"Wrobel","year":"2015","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00192-016-3027-3","article-title":"Fourteen-day administration of corticosterone may induce detrusor overactivity symptoms","volume":"27","author":"Wrobel","year":"2016","journal-title":"Int. Urogynecol. J."},{"key":"B54","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejphar.2018.08.027","article-title":"Inhibition of Rho kinase by GSK 269962 reverses both corticosterone-induced detrusor overactivity and depression-like behaviour in rats","volume":"837","author":"Wrobel","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0060314","article-title":"GPR55, a G-protein coupled receptor for lysophosphatidylinositol, plays a role in motor coordination","volume":"8","author":"Wu","year":"2013","journal-title":"PloS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ejphar.2007.12.005","article-title":"A mouse model of depression induced by repeated corticosterone injections","volume":"581","author":"Zhao","year":"2008","journal-title":"Eur. J. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01002\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T06:23:32Z","timestamp":1594189412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.01002\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,8]]},"references-count":56,"alternative-id":["10.3389\/fphar.2020.01002"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.01002","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,8]]},"article-number":"1002"}}